AMEDISYS INC's ticker is AMED and the CUSIP is 023436108. A total of 396 filers reported holding AMEDISYS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $374,000 | -47.8% | 4,054 | -48.5% | 0.00% | 0.0% |
Q2 2023 | $717,000 | +38.4% | 7,866 | +12.8% | 0.00% | 0.0% |
Q1 2023 | $518,000 | -0.2% | 6,976 | +14.8% | 0.00% | 0.0% |
Q4 2022 | $519,000 | -21.4% | 6,077 | -10.6% | 0.00% | -50.0% |
Q3 2022 | $660,000 | -13.8% | 6,796 | -7.0% | 0.00% | 0.0% |
Q2 2022 | $766,000 | -41.5% | 7,304 | -4.1% | 0.00% | -33.3% |
Q1 2022 | $1,310,000 | +50.7% | 7,619 | +40.4% | 0.00% | +50.0% |
Q4 2021 | $869,000 | +32.9% | 5,426 | +23.2% | 0.00% | 0.0% |
Q3 2021 | $654,000 | -36.4% | 4,405 | +3.2% | 0.00% | -33.3% |
Q2 2021 | $1,029,000 | +7.5% | 4,270 | +18.7% | 0.00% | 0.0% |
Q1 2021 | $957,000 | +19.3% | 3,597 | +32.7% | 0.00% | 0.0% |
Q4 2020 | $802,000 | +27.5% | 2,710 | +1.0% | 0.00% | 0.0% |
Q3 2020 | $629,000 | +19.6% | 2,684 | +1.6% | 0.00% | 0.0% |
Q2 2020 | $526,000 | +28.9% | 2,642 | +18.0% | 0.00% | 0.0% |
Q1 2020 | $408,000 | +56.9% | 2,239 | +15.5% | 0.00% | +200.0% |
Q3 2019 | $260,000 | +12.6% | 1,939 | +4.4% | 0.00% | 0.0% |
Q2 2019 | $231,000 | – | 1,858 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RIVERBRIDGE PARTNERS LLC | 1,693,656 | $291,800,000 | 3.30% |
Kent Lake Capital LLC | 30,000 | $5,169,000 | 3.21% |
Lipe & Dalton | 22,802 | $3,929,000 | 1.92% |
RK Capital | 54,900 | $9,459,000 | 1.86% |
Millrace Asset Group, Inc. | 14,651 | $2,524,000 | 1.83% |
Integral Health Asset Management, LLC | 40,000 | $6,892,000 | 1.79% |
Bridge City Capital, LLC | 19,175 | $3,304,000 | 1.54% |
Sivik Global Healthcare LLC | 20,000 | $3,446,000 | 1.42% |
Bell Asset Management Ltd | 47,207 | $8,133,000 | 1.40% |
Advantage Alpha Capital Partners LP | 53,680 | $9,249,000 | 1.38% |